A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of a Halobetasol/Tazarotene Fixed Combination in the Treatment of Plaque Psoriasis.

Sugarman, Jeffrey L; Gold, Linda Stein; Lebwohl, Mark G; Pariser, David M; Alexander, Binu J; Pillai, Radhakrishnan

Sugarman, Jeffrey L; Gold, Linda Stein; Lebwohl, Mark G; Pariser, David M; Alexander, Binu J; Pillai, Radhakrishnan.

J Drugs Dermatol ; 16(3): 197-204, 2017 Mar 01.

Article in En | MEDLINE | ID: mdl-28301614

Subject(s)

Clobetasol/analogs & derivatives; Dermatologic Agents/therapeutic use; Glucocorticoids/therapeutic use; Nicotinic Acids/therapeutic use; Psoriasis/drug therapy; Administration, Cutaneous; Clobetasol/administration & dosage; Clobetasol/adverse effects; Clobetasol/therapeutic use; Dermatologic Agents/administration & dosage; Dermatologic Agents/adverse effects; Double-Blind Method; Drug Combinations; Female; Glucocorticoids/administration & dosage; Glucocorticoids/adverse effects; Humans; Male; Nicotinic Acids/administration & dosage; Nicotinic Acids/adverse effects; Pharmaceutical Vehicles/administration & dosage; Severity of Illness Index; Skin Cream; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Clobetasol / Dermatologic Agents / Glucocorticoids / Nicotinic Acids Type of study: Clinical_trials Limits: Female / Humans / Male Language: En Journal: J Drugs Dermatol Journal subject: DERMATOLOGIA Year: 2017 Type: Article

Search on Google

XML

PubMed Links